Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyApar Kishor Ganti, Miranda Hughes, Billy W. Loo et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 459
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Michael J. Dennis et al.|Cancer Discovery|2023Cited by 181
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cellsMoiez Ali, Kris C. Wood, Hazel X. Ang et al.|Science Translational Medicine|2022Cited by 45
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or ChemotherapyKai He, Ticiana Leal, David Berz et al.|Journal of Thoracic Oncology|2023Cited by 38
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancersCollin M. Blakely, Trever G. Bivona|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 2